ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Eris Lifesciences Ltd allotted 24,396 equity shares on May 11, 2026, under its ESOP-2021 scheme. The allotment covers three grant years: 6,415 shares (Rs. 557.24 each), 8,281 shares (Rs. 510.32 each), and 9,673 shares (Rs. 728.16 each). The paid-up share capital increased marginally from ₹13,85,42,887 to ₹13,85,67,256, reflecting the exercise of employee stock options. This is a routine ESOP-driven dilution event with no material impact on the company's financial position.
Minor equity dilution from employee stock option exercises; negligible per-share impact. Positive signal of employee retention and alignment as key personnel are exercising options.